Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tamayo, Rafael Ríos
GEM21menos65, NCT05558319: NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide	Not yet recruiting	3	480	Europe	Bortezomib, Isatuximab, Iberdomide, Lenalidomide, Dexamethasone	PETHEMA Foundation, Bristol-Myers Squibb, Sanofi, Adknoma, Start from scratch	Newly Diagnosed Multiple Myeloma	04/27	04/29
NCT05297240: Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.	Recruiting	N/A	170	Europe	Belantamab mafodotin	PETHEMA Foundation, GlaxoSmithKline	RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA	12/22	12/22